Antidepressant drugs: new reports on adverse effects and efficacy
Wynn, R.L.
General Dentistry 58(6): 474-477
2010
ISSN/ISBN: 0363-6771 PMID: 21062715 Document Number: 641663
Document emailed within 1 workday
Related Documents
Janiec, W.; Pietryka, B.; Sliwiński, L.; Leszczyńska, J. 1985: Adverse effects of nonsteroid anti-inflammatory drugs. I. Adverse effects of salicylic, phenylacetic and propionic acids Wiadomosci Lekarskie 38(22): 1613-1619Stricker, B.H.; Ottervanger, J.P.; van der Klauw, M.M. 1994: Registration of suspected adverse effects by the Bureau Adverse Effects Drugs; research activities in 1993 Nederlands Tijdschrift Voor Geneeskunde 138(42): 2110-2113
Janiec, W.; Pietryka, B.; Pytlik, M.; Leszczyńska, J. 1985: Adverse effects of non-steroidal anti-inflammatory drugs. II. Adverse effects of heterocyclic enols Wiadomosci Lekarskie 38(24): 1745-1750
Jaźwińska-Tarnawska, E.; Wiela-Hojeńska, A.; Wolańczyk-Medrala, A.; Patkowski, J.; Nittner-Marszalska, M.; Głowacka, K. 2012: Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center Acta Poloniae Pharmaceutica 69(5): 979-984
Gaillard, J.M.; de St Hilaire-Kafi, S. 1985: Sleep, depression and the effects of antidepressant drugs Acta Psychiatrica Belgica 85(5): 561-567
1988: Reports of adverse effects in 1987: reduction since last year Lakartidningen 85(21): 1906-1908
O'Donnell, J.M.; Seiden, L.S. 1983: Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs Journal of Pharmacology and Experimental Therapeutics 224(1): 80-88
Stahl, S.M. 1998: Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects Journal of Clinical Psychiatry 59(Suppl): 23-29
Bowles, G.C. 1970: Modern pharmacy practice. N.A.S-N.R.C. reports efficacy of drugs released before 1962 Modern Hospital 115(1): 108
Danie, W.A.; Syrek, M.; Ryłko, Z.; Wójcikowski, J. 2001: Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes Polish Journal of Pharmacology 53(4): 351-357
Coquoz, D.; Porchet, H.C.; Dayer, P. 1991: Central analgesic effects of antidepressant drugs with various mechanisms of action: desipramine, fluvoxamine and moclobemide Schweizerische Medizinische Wochenschrift 121(49): 1843-1845
Brennan, F.J.; Cassidy, D.M. 1988: Effects of tetracyclic antidepressant drugs on the electrophysiological properties of canine cardiac Purkinje fibres Canadian Journal of Cardiology 4(6): 281-286
El-Dakhakhny, M.; Abdel el-Latif, H.A.; Ammon, H.P. 1996: Different effects of the antidepressant drugs imipramine, maprotiline and bupropion on insulin secretion from mouse pancreatic islets Arzneimittel-Forschung 46(7): 667-669
Menkes, D.B.; Wood, K.; Wooods, D. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 476
Fahy, T.J. 1994: Efficacy and adverse effects of moclobemide Lancet 343(8895): 475-476
Andreasen, P.B. 1994: Adverse effects of drugs and the liver Ugeskrift for Laeger 156(2): 151
Dalman, C.; Lönnerholm, G.; Wiholm, B.E. 1988: Adverse effects of drugs in children Lakartidningen 85(40): 3280-3283
Kuzelová, M.; Chalachanová, E.; Kriska, M.; Svec, P. 1992: Adverse effects of drugs in neonates Ceskoslovenska Pediatrie 47(2): 100-102
Uvnäs, B.; Westerholm, B. 1970: Report on adverse effects of drugs (8) Lakartidningen 67(50): 5883-5884
Braun, P. 1972: Diagnosing adverse effects of drugs Orvosi Hetilap 113(52): 3140-3141